Neuberg Diagnostics, founded in 2017 said it has raised ₹940 crore from Kotak Alt to support growth. 

GSK Velu, Founder and MD, Neuberg Diagnostics, said, “This funding will enable us to enhance our capabilities in the areas of personalised medicine, integrated diagnostics and inorganically expand our footprint across the country.”

“As we prepare for an IPO, we remain committed to making high-quality diagnostics accessible to all, ensuring that our services continue to meet the evolving needs of clinicians and patients,” Mr. Velu said. 

Rahul Shah, Partner, Kotak Alt said, “The investment reflects our confidence in Neuberg’s vision and potential. We are confident that this strategic investment will play a key role in increasing the scale of Neuberg Diagnostics and help the company get ready for their upcoming IPO.”

“This investment solidifies our commitment to supporting quality healthcare solutions that improve patient outcomes and accessibility,” he added. 

The company headquartered in Chennai, has rapidly grown through acquisitions and has a network spanning over 10,000 touch points and over 250 labs across 250 cities.

It has the capability to perform over 5,000 types of tests.